CD28 and malignant colon neoplasm: This mechanism waspotentiated in colon cancers where the MMR gene defect was not due to a germline mutation, since the CD80-CD28 cascade may be less frequently damaged by DNA mismatch, thus favouring Th1 recruitment and leading to a significant better survival.